Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

Ersboll, M; Jurgens, M; Hasbak, P; Kjaer, A; Wolsk, E; Zerahn, B; Brandt-Jacobsen, NH; Gaede, P; Rossing, P; Faber, J; Inzucchi, SE; Gustafsson, F; Schou, M; Kistorp, C

Ersboll, M (通讯作者),Copenhagen Univ Hosp Herlev Gentofte, Dept Cardiol, Herlev, Denmark.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022; 38 (3): 579

Abstract

To investigate the effects of 13 weeks treatment with empagliflozin in patients with high-risk type-2 diabetes mellitus on echocardiographic measures ......

Full Text Link